Plasma nucleic acid analysis by massively parallel sequencing: pathological insights and diagnostic implications

Area of Science:

• Molecular Biology
• Genomics
• Diagnostics

Background:

• Increasing interest in circulating DNA (ctDNA) in human plasma over the past 15 years.
• ctDNA originates from fetuses, tumors, transplanted organs, and injured tissues.
• Massively parallel sequencing (MPS) provides a powerful tool for genome-wide analysis of ctDNA.

Purpose of the Study:

• To explore the diagnostic applications of ctDNA using MPS.
• To demonstrate the utility of MPS for detecting various pathological conditions through ctDNA analysis.
• To advance molecular diagnostics and understanding of circulating nucleic acid biology.

Main Methods:

• Genome-wide analysis of circulating DNA in plasma using massively parallel sequencing.
• Detection of fetal chromosomal aneuploidies in maternal plasma.
• Identification and detection of tumor-associated chromosomal translocations in plasma.
• Analysis of quantitative aberrations in serum for cancer detection.
• Application of MPS to plasma of transplant recipients for rejection detection.

Main Results:

• Robust detection of fetal chromosomal aneuploidies from maternal plasma.
• Construction of genome-wide fetal genetic maps.
• Identification of tumor-associated chromosomal translocations in plasma.
• Detection of malignancy-associated quantitative aberrations in serum.
• Development of an approach for detecting transplant rejection via plasma ctDNA analysis.

Conclusions:

• MPS of ctDNA provides novel modalities for molecular diagnostics.
• This approach enhances the understanding of circulating nucleic acid biology.
• ctDNA analysis holds significant promise for early disease detection and monitoring across various pathologies.